22nd Century Group, Inc. (XXII)
After hours:
| Previous Close | 1.7600 |
| Open | 1.8100 |
| Bid | 1.7800 x 3200 |
| Ask | 1.8000 x 2200 |
| Day's Range | 1.7000 - 1.8119 |
| 52 Week Range | 1.4200 - 5.2500 |
| Volume | |
| Avg. Volume | 1,547,706 |
| Market Cap | 291.319M |
| Beta (5Y Monthly) | 2.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
Complete Hemp/Cannabis Solution from Receptor Science and Plant Genetics to Final Ingredients and CDMOConsistent, Reliable, High-Quality Cannabinoids and Cannabinoid Infused Products for ConsumersAcquisition Immediately Accretive; Will Double 22nd Century Revenue BUFFALO, N.Y., May 18, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced pl
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
Provides Transformational Platform to Rapidly Grow Hemp/Cannabis FranchiseTransaction Immediately Accretive and Will Double Company’s Total RevenueAdds Significant Commercial Scale to Existing Hemp/Cannabis FranchiseGVB Biopharma has Achieved Strong Growth and Leading Market Share in Hemp-Derived Active Ingredients BUFFALO, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced
- GlobeNewswire
22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
Launched VLN® Pilot Program in Chicago with Circle K as First Retail Trade PartnerBegan VLN® Shipments to South Korea for First International LaunchFDA’s Proposed Menthol Ban Could Leave VLN® Menthol King as the Only Menthol Cigarette on the MarketAchieved Breakthrough in Hemp/Cannabis Plant Transformation TechnologyFirst Quarter Net Sales $9.0 million, up 33% Year-Over-Year BUFFALO, N.Y., May 05, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnol
